CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 233 filers reported holding CLOVIS ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $128,000 | -30.4% | 1,886 | -15.5% | 0.01% | -40.0% |
| Q3 2017 | $184,000 | +2.2% | 2,233 | -55.3% | 0.01% | +66.7% |
| Q3 2016 | $180,000 | -94.9% | 5,000 | -87.0% | 0.01% | -93.5% |
| Q3 2015 | $3,532,000 | +14.8% | 38,410 | +9.7% | 0.09% | +16.2% |
| Q2 2015 | $3,076,000 | +89.9% | 35,000 | +21.0% | 0.08% | +70.2% |
| Q4 2014 | $1,620,000 | +20.5% | 28,931 | -2.4% | 0.05% | +51.6% |
| Q3 2014 | $1,344,000 | – | 29,640 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |